Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Clinical trial NCT01081223 · COMPLETED
Trial details
- NCT number
- NCT01081223
- Sponsor
- TVAX Biomedical
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.